Hyglos
Bernried
About Hyglos
As an established Biotech company, Hyglos is dedicated to exploit the biochemical principles evolved by bacteriophages for healthcare applications. The abundance of bacteriophages in nature and the unmet precision in occupying and destroying their host bacteria provide an almost unlimited pool for target-specific protein tools.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Funding stage: M&A
- Last round: Series C (Aug 2005)
- Website: hyglos.de
- Phone: 49 8158 9060 0
Industries & Categories
Biopharma, Biotechnology, Developer Platform, Medical
Social Profiles
Canonical: https://fsome.com/organization/hyglos-2037154 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.